Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Filter Integrity Testing

Posted on By

SOP for Filter Integrity Testing

Standard Operating Procedure for Filter Integrity Testing

1) Purpose

The purpose of this SOP is to outline the procedure for performing filter integrity testing to ensure that the sterile filters used in the production of ocular dosage forms are functioning correctly and effectively retaining microorganisms.

2) Scope

This SOP applies to all sterile filters used in the production of ocular dosage forms within the pharmaceutical manufacturing facility, ensuring the integrity of the filters before and after use.

3) Responsibilities

The responsibilities include performing the filter integrity tests, documenting the results, and maintaining the testing equipment. Production staff are responsible for following this procedure, and the maintenance team is responsible for regular checks and calibration of the testing equipment.

See also  SOP for Sealing Line for Gels

4) Procedure

4.1 Pre-Use Integrity Testing

  1. Assemble the filter system and ensure it is properly connected to the integrity testing equipment.
  2. Prime the filter with sterile water or an appropriate test fluid as specified by the filter manufacturer.
  3. Perform the integrity test (e.g., bubble point test, diffusion test, or pressure hold test) according to the filter manufacturer’s instructions.
  4. Record the test results, ensuring they meet the acceptance criteria specified by the filter manufacturer.
  5. If the filter fails the integrity test, replace it with a new filter and repeat the testing procedure.

4.2

Post-Use Integrity Testing

  1. After the filtration process, perform the integrity test on the used filter to ensure it remained intact throughout the process.
  2. Use the same testing method as the pre-use integrity test (e.g., bubble point test, diffusion test, or pressure hold test).
  3. Record the test results, ensuring they meet the acceptance criteria specified by the filter manufacturer.
  4. If the filter fails the post-use integrity test, investigate the cause and assess the impact on the product batch. Follow the facility’s deviation handling procedures.
See also  SOP for Storage System for Finished Products

4.3 Maintenance and Calibration

  1. Perform regular maintenance on the filter integrity testing equipment as per the manufacturer’s recommendations.
  2. Calibrate the integrity testing equipment periodically to ensure accurate results.
  3. Document all maintenance and calibration activities in the equipment logbook.

5) Abbreviations, if any

None

6) Documents, if any

  1. Integrity test records
  2. Equipment logbook
  3. Calibration certificates

7) Reference, if any

GMP Guidelines for filter integrity testing in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Ocular (Eye) Dosage Forms Tags:Aseptic processing, Bioavailability in ocular drugs, Blow-fill-seal technology, Cleanroom standards, Conjunctival inserts, Contact lenses drug delivery, Drug stability testing, Ethylene oxide sterilization, Eye drops SOP, Gamma sterilization, Heat sterilization, HEPA filtration, Intraocular implants, Intraocular injections, Microemulsions in ophthalmics, Mucoadhesive polymers, Multidose ophthalmic bottles, ocular dosage forms, Ocular drug delivery, Ointment preparation, Ophthalmic formulations, Ophthalmic gels, Ophthalmic suspensions, Ophthalmic viscosity, Preservative-free formulations, Solubility issues, SOP for Ocular Dosage Forms, Sterile filtration, Sterile solutions, Sterility testing, Terminal sterilization, Topical ocular drugs

Post navigation

Previous Post: SOP for Handling and Storage of Raw Materials
Next Post: SOP for Supplier Qualification for Raw Materials in MDI Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version